This product includes the webinar and SAM credit

---

Speaker Lynette M. Sholl, MD	Moderator Christina Lockwood, PhD

Description: This session will focus on the principles of cell free DNA biology and approaches to detecting genomic alterations in circulating tumor DNA relevant to the diagnosis and management of solid tumor patients. Areas of controversy, as well as technical developments that may expand the use of liquid biopsy in clinical medicine, will be addressed. 

Duration: 1 hr

Level of Instruction: Basic

Last day to purchase course and claim credit: December 31, 2020

Maximum SAM credit available: 1.0

This webinar is part 4 of a five-part series aimed at breaking down barriers to NSCLC testing and treatment. If you'd like more information about the series go here.

Supported by an educational grant provided by AstraZeneca

---

How to claim credit: To earn SAM credit, all learners must watch the webinar, achieve a minimum score of 80% on the online quiz, and complete an online survey. To access the quiz, click "Submit credit" on the course homepage or click on "My Credit" on the menu to the left and then "submit credit" for the appropriate course.

This course is approved by the American Board of Pathology for 1.0 SAM credits.Physicians should only claim credit commensurate with the extent of their participation in the activity. Participants must successfully complete the online modular exams (answering at least 80% of the questions in a topic module correctly).

SAM questions edited by: Rajyasree Emmadi, MD

* You may not submit SAMs and CME/CMLE credit for the same content.

---

You may also be interested in:

• More webinars in this series
• Cell Free DNA Testing for Cancer: Clinical Validation, Implementation and Applications
• AMP Europe 2018: Presentation Recordings: Recent Advances in Liquid Biopsies: Challenges and Solutions
• More on AMPEDTM

Note: Members of AMP can access many of the webinars at no cost or a deep discount. Join the AMP Family!

All sales are final. No refunds will be issued.

No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP

Recognize the biological and technical challenges that limit the sensitivity of liquid biopsy
Identify factors that may lead to discrepant results when comparing tumor genomic alterations across platforms or biopsy types

Pre-Test for Liquid Biopsies - Promises and Pitfalls (+SAM)

Liquid Biopsies - Promises and Pitfalls

Post-Test for Liquid Biopsies - Promises and Pitfalls (+SAM)

QA Session

How to Claim SAM

Individual topic purchase: Selected